Burning Point Medical key facts
- Developer of pharmaceutical solutions designed for hypertensive and spastic pain disorders.
- It has raised $22.3M; the latest was Later Stage VC ($6.8M) in Apr 2025.
- Notable investors include Nanjing Innovation Capital Group, Nanjing Industrial Development Fund, BGI Co-Win, Fosun Pharma, Guohai Innovation Capital Investment Management — 8 tracked in total.
- Status: Privately Held (backing).
- ·Watch Burning Point Medical: the Monday email on marks, rounds and moves
Burning Point Medical funding rounds
No funding rounds for Burning Point Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Burning Point Medical investors
8 investors are on record for Burning Point Medical, including Nanjing Innovation Capital Group, Nanjing Industrial Development Fund, BGI Co-Win and Fosun Pharma.
About Burning Point Medical
Developer of pharmaceutical solutions designed for hypertensive and spastic pain disorders. The company's products aim to treat hypertension, relieve chest pain and spastic pains, enabling healthcare professionals to prescribe more effective treatments to their patients.
- Sector
- Healthcare
- HQ
- Nanjing, China
- Founded
- 2019
- Website
- bpbiopharm.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
Burning Point Medical doesn't have a valuation on record yet — one is published once a priced round, a reported valuation, fund marks, or secondary prints surface in our sources. The rest of the record below builds toward it.